Company intelligence / Profile preview
Bluefin Biomedicine
Beverly, Massachusetts, United Statesbluefinbiomed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bluefin Biomedicine is developing antibody-based treatments for orphan cancer indications, focusing on underserved patients. The company uses proprietary proteomics, transcriptomics, and bioinformatics methods to study cancer tumors and identify differentially expressed cancer antigens for therapeutic antibody development.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-based therapeutics
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Bluefin Biomedicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bluefin Biomedicine.